Companies:
49,719
Total Market Cap:
134152149434254.58
Global Rank
#28261
Country Rank
#1566
Market Cap
58.92 M
Price
1.9
Change (%)
3.35%
Volume
91,011
Genome & Company (KOSDAQ-314130) Stock Split History
This company has undergone a total of one stock splits throughout its history. One forward splits were executed, enhancing liquidity and increasing share accessibility. The most recent split occurred on 08/06/2024 with a ratio of 2-for-1. If an investor had purchased one share prior to the first split on 08/06/2024, that single share would now have grown to 2 shares. These adjustments reflect the company's strategic efforts to align stock performance with market conditions.
| Date | Split Ratio | Multiple | Cumulative multiple | Type |
|---|---|---|---|---|
| 08/06/2024 | 2:1 | x2 | x2 | Forward |
Frequently Asked Questions
-
How much would Genome & Company stock be worth if it never split?If Genome & Company (stock symbol: KOSDAQ-314130) had never undergone any stock splits, its price per share today would be approximately 3.79 USD. This calculation reflects the cumulative effect of all splits, including the most recent split (ratio: 2-for-1) that occurred on 08/06/2024.
-
Has Genome & Company stock ever split?Genome & Company (stock symbol: KOSDAQ-314130) has undergone a total of one stock splits. The most recent split occurred on 08/06/2024. One share bought prior to the first split on 08/06/2024 would now equal 2.00 shares.
-
Will Genome & Company stock split again?Genome & Company (stock symbol: KOSDAQ-314130) has undergone one stock splits in its history. The most recent split, a 2-for-1 split, occurred on 08/06/2024. While future splits are not guaranteed, significant increases in stock price could prompt consideration for another split.